The Nasdaq Composite Index has nearly doubled since the end of 2011, led by its riskiest sector: biotechnology.But biotech companies vary more than most in other industries. Some have no hopes of ever making money. And others are backed by products that are established in the marketplace and are quite profitable.The Nasdaq Biotechnology Index NBI, +0.40% has risen 227% since […]
Healthcare
RayVa Patent Award Sends Apricus Biosciences Inc (APRI) Stock Trading Up
Apricus Biosciences announces on Tuesday that it has been awarded Rayva’s Patent by USPTO; stock soars by 15.58%
APRI
By: Martin BlancPublished: Jan 28, 2015 at 11:41 am EST
Apricus Biosciences Inc. (NASDAQ:APRI) is trading up by around 15.58% as of 11:14 AM EST. The buying spree on the stock followed the announcement […]
Healthcare
RayVa Patent Award Sends Apricus Biosciences Inc (APRI) Stock Trading Up
Apricus Biosciences announces on Tuesday that it has been awarded Rayva’s Patent by USPTO; stock soars by 15.58%
APRI
By: Martin BlancPublished: Jan 28, 2015 at 11:41 am EST
Apricus Biosciences Inc. (NASDAQ:APRI) is trading up by around 15.58% as of 11:14 AM EST. The buying spree on the stock followed the announcement […]
By Ben LevisohnYes, say the folks at Nomura, who recommend buying Celgene (CELG), Receptos(RCPT), Gilead Sciences (GILD), Neurocrine Biosciences (NBIX), and Alexion Pharmaceuticals (ALXN), in that order. Analyst M. Ian Somaiya and team explain why:
October has historically been a weak month for biotech, with the Nasdaq Biotechnology Index underperforming the S&P 500 in 14 out the last 20 years. We believe […]
